Speaker illustration

Doctor Khava Dzaurova

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiarrhythmic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb